Evidence map›Paper›PMID 36536289›Full record

ArticleBMC bioinformatics2022

Joint learning sample similarity and correlation representation for cancer survival prediction.

Yaru Hao, Xiao-Yuan Jing, Qixing Sun

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yaru HaoSchool of Computer Science, Wuhan University, Wuhan, China. hyr2018@whu.edu.cn.
Xiao-Yuan JingSchool of Computer Science, Wuhan University, Wuhan, China. jingxy_2000@126.com.
Qixing SunSchool of Computer Science, Wuhan University, Wuhan, China.
Wuhan University · CN

Funding

the Innovation Group of Guangdong Education Department under Grant No. 2020KCXTD014the Natural Science Foundation of Guangdong Province under Grant No. 2019A1515011076the NSFC-Key Project of General Technology Fundamental Research United Fund under Grant No. U1736211the NSFC-Key Project under Grant No. 61933013the project of State Key Laboratory for Novel Software Technology under Grant No. KFKT2021B29
6 · The paper itself

Abstract

backgroundAs a highly aggressive disease, cancer has been becoming the leading death cause around the world. Accurate prediction of the survival expectancy for cancer patients is significant, which can help clinicians make appropriate therapeutic schemes. With the high-throughput sequencing technology becoming more and more cost-effective, integrating multi-type genome-wide data has been a promising method in cancer survival prediction. Based on these genomic data, some data-integration methods for cancer survival prediction have been proposed. However, existing methods fail to simultaneously utilize feature information and structure information of multi-type genome-wide data.

resultsWe propose a Multi-type Data Joint Learning (MDJL) approach based on multi-type genome-wide data, which comprehensively exploits feature information and structure information. Specifically, MDJL exploits correlation representations between any two data types by cross-correlation calculation for learning discriminant features. Moreover, based on the learned multiple correlation representations, MDJL constructs sample similarity matrices for capturing global and local structures across different data types. With the learned discriminant representation matrix and fused similarity matrix, MDJL constructs graph convolutional network with Cox loss for survival prediction.

conclusionsExperimental results demonstrate that our approach substantially outperforms established integrative methods and is effective for cancer survival prediction.

Indexed as

NeoplasmsGenomeGenomicsHigh-Throughput Nucleotide SequencingHumansCancer survival predictionCorrelation representationFeature informationSimilarity matrixStructure information

Identifiers

PMID36536289
PMCPMC9761951
OpenAlexW4312114970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.